aMoon Fund
aMoon is a leading healthtech &a; life sciences venture capital firm.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed aMoon Fund Information
Geographic Data
Address: 34 Yerushalaim Rd
City: Raanana
State: tel aviv district
Zip: 4350110
Country: IL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
6,356,548Website Global Rank
970Website Monthly Traffic
Twitter Followers
Description
aMoon is a leading healthtech &a; life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2020 | Mobilion Systems | Series B | 35M |
| 6/2019 | DayTwo | Series B | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 4/2011 | CartiHeal | Series C | 300k |
| 3/2021 | Scipher Medicine | Series C | 82M |
| 4/2020 | AtaCor Medical | Series B | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 8/2019 | MDClone | Series B | 26M |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 5/2021 | DayTwo | Series B | 37.4M |
| 4/2021 | Sera Prognostics | Series E | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
| 9/2022 | Lyfegen | Series A | 8M |
| 5/2019 | Ayala Pharmaceuticals | Series B | 0 |
| 1/2020 | Mammoth Biosciences | Series B | 0 |
| 12/2019 | Seer | Series D | 55M |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 3/2021 | Ibex Medical Analytics | Series B | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 11/2022 | Ibex Medical Analytics | Debt Financing | 0 |
| 9/2019 | Igentify | Equity | 10.5M |
| 8/2017 | Karius | Series A | 59M |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 11/2022 | Nectin Therapeutics | Series A | 25M |
| 3/2021 | Absci | Venture Round | 0 |
| 12/2019 | NanoGhosts | Venture Round | 5M |
| 7/2021 | Sentient Med | Pre Seed Round | - |
| 3/2019 | Theranica | Series B | 35M |
| 8/2022 | Theranica | Series C | 0 |
| 4/2021 | AltruBio | Series A | 63M |
| 12/2019 | Vocalis Health | Venture Round | 9M |
| 7/2018 | Nobio | Venture Round | 3.6M |
| 2/2022 | Omada Health | Series E | 0 |
| 11/2020 | Viracta Therapeutics | Series E | 0 |
| 4/2022 | Eleos Health | Series A | 0 |
| 9/2018 | AtaCor Medical | Series A | 9M |
| 3/2018 | Medial EarlySign | Series B | 30M |
| 9/2020 | PrognomiQ | Venture Round | 0 |
| 10/2020 | SOPHiA GENETICS | Series F | 0 |
| 4/2021 | Biosplice Therapeutics | Venture Round | 0 |
| 3/2019 | Ibex Medical Analytics | Series A | 11M |
| 7/2020 | Seer | Series D | 55M |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 6/2020 | CuResponse | Series A | 6M |
| 2/2021 | Viracta Therapeutics | Post-IPO Equity | 65M |
| 3/2022 | Satellite Bio | Series A | 0 |
| 9/2020 | MiNA Therapeutics | Series A | 29.5M |
| 7/2020 | Nectin Therapeutics | Venture Round | 6M |
| 2/2020 | AposHealth | Series A | 11M |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 4/2022 | Eleos Health | Series A | 0 |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 3/2022 | Satellite Bio | Series A | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 2/2022 | Omada Health | Series E | 0 |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
